Parthenolide modulates the NF-kappaB-mediated inflammatory responses in experimental atherosclerosis
about
HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosisLocal non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes.Reduction in dietary omega-6 polyunsaturated fatty acids: eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse.Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasomeHeck products of parthenolide and melampomagnolide-B as anticancer modulators that modify cell cycle progressionIdentification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activity in vitro and in vivoNitroglycerin alters matrix remodeling proteins in THP-1 human macrophages and plasma metalloproteinase activity in rats.The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats.Gene Deficiency in Activating Fcγ Receptors Influences the Macrophage Phenotypic Balance and Reduces Atherosclerosis in Mice.Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout miceA novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes.The NF-κB inhibitory proteins IκBα and IκBβ mediate disparate responses to inflammation in fetal pulmonary endothelial cells.NF-kappaB signaling pathway and its therapeutic implications in human diseases.Targeting inflammation in cardiovascular diseases. still a neglected field?NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links.Analysis of sequence, structure of GAPDH of Leishmania donovani and its interactions.Molecular mechanism of a new Laminaria japonica polysaccharide on the suppression of macrophage foam cell formation via regulating cellular lipid metabolism and suppressing cellular inflammation.Gremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway.Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling.Fcγ receptor deficiency attenuates diabetic nephropathy.Parthenolide inhibits proliferation of vascular smooth muscle cells through induction of G0/G1 phase cell cycle arrest.The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-κB pathway and proinflammatory factors in vascular smooth muscle cells.Parthenolide is neuroprotective in rat experimental stroke model: downregulating NF-κB, phospho-p38MAPK, and caspase-1 and ameliorating BBB permeability.Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis.Sesquiterpene lactone parthenolide attenuates production of inflammatory mediators by suppressing the Toll-like receptor-4-mediated activation of the Akt, mTOR, and NF-κB pathways.DBZ blocks LPS-induced monocyte activation and foam cell formation via inhibiting nuclear factor-ĸB.Protective effect of sesquiterpene lactone parthenolide on LPS-induced acute lung injury.Salusin-β accelerates inflammatory responses in vascular endothelial cells via NF-κB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro.Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.
P2860
Q28569716-436B97C1-18F7-4BDA-B6E0-5742F45D2BAAQ33536636-97A640F8-8BE4-4882-B672-A1755A2C09E0Q33679873-2DFAD923-DE0D-46EE-9910-3840F0703D27Q33744674-921A5816-0E2A-4EF6-8DFD-E6A29D362523Q34205587-77F3E299-18A8-48BC-A3D5-6C251817D00BQ34391237-B2CDBC01-D1E8-4A22-AA31-7E242B9FE041Q34574503-52B7D6A0-61EC-4DD8-A329-5BABA35130A2Q34769627-25E14D77-5A8B-4C56-ABB3-B0C5CFD7698AQ34785574-9C676C03-C3CD-4221-A706-C99D38447B07Q35080598-7A258695-13CC-42F9-86BE-ADB9FEDBF29CQ35711283-95C75392-4198-481B-B7BF-00A823A81F06Q36674163-BF3D02EC-6B49-4830-96FF-738883FACA22Q37293337-AEFB3C41-DF31-4CC0-A9F4-61DAB94721B8Q37925018-94A72EF2-00F5-4D4C-BA2D-F44DAF4A3AABQ38227386-FF88586A-07DB-4DA2-BC38-1554B6D6EA86Q38323241-22D74943-E916-4D04-AFED-6659FA2D26B6Q38855556-6900A18B-B03C-4FE4-9E10-FFA6C4A26EBAQ38895003-46B5EAAC-2B45-4E5B-AA64-018F75F89F2FQ39688016-A4D1B638-CFAD-442C-BDB5-5F2A7587C022Q41951561-409CABF8-C2BE-4D8B-BD2C-FA97CA57D41DQ42875494-61545470-AF91-4A26-99EC-38F40FE45E19Q42876722-1ED63D31-9BB3-451E-8D4A-860DD6C565C5Q43070854-770A520B-F714-436C-93D2-F833D6978A58Q43162731-2986CC22-88DC-4BFC-957D-CC54556A3B35Q46027542-732D4606-78E1-4A26-8936-64A339F9FEC5Q46729114-0C30BE6B-5E62-4082-BDCC-28A02F81D08AQ47241282-DCAF008A-EC91-4A63-ACA4-2CA1EBB938D6Q48967687-FA9A4765-BD77-4A7C-AEB7-6E4174833F4DQ50247547-6D2C76D8-0422-45ED-89C9-D320607A3DD5Q55058976-D1174DFE-22A6-442C-A667-8829AE44606E
P2860
Parthenolide modulates the NF-kappaB-mediated inflammatory responses in experimental atherosclerosis
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Parthenolide modulates the NF- ...... n experimental atherosclerosis
@ast
Parthenolide modulates the NF- ...... n experimental atherosclerosis
@en
Parthenolide modulates the NF- ...... n experimental atherosclerosis
@nl
type
label
Parthenolide modulates the NF- ...... n experimental atherosclerosis
@ast
Parthenolide modulates the NF- ...... n experimental atherosclerosis
@en
Parthenolide modulates the NF- ...... n experimental atherosclerosis
@nl
prefLabel
Parthenolide modulates the NF- ...... n experimental atherosclerosis
@ast
Parthenolide modulates the NF- ...... n experimental atherosclerosis
@en
Parthenolide modulates the NF- ...... n experimental atherosclerosis
@nl
P2093
P921
P3181
P1476
Parthenolide modulates the NF- ...... n experimental atherosclerosis
@en
P2093
Carmen Gómez-Guerrero
Guadalupe Ortiz-Muñoz
Guillermo Sanjuán
Jesús Egido
Julia Blanco
Luis Ortega
Oscar López-Franco
Purificación Hernández-Vargas
Yusuke Suzuki
P304
P3181
P356
10.1161/01.ATV.0000229659.94020.53
P407
P577
2006-08-01T00:00:00Z